The emergence of resistance to fluoroquinolones in virtually all speci
es of bacteria was recognized soon after the introduction of these com
pounds for clinical use more than 10 years ago. Various resistance mec
hanisms, often interdependent, may explain different levels of resista
nce. Epidemiological factors, local antibiotic policies, patients' cha
racteristics, origin of the strains, and geographic location are among
the factors contributing to highly variable resistance rates. During
the last several years, resistance to fluoroquinolones has remained ve
ry high among methicillin-resistant Staphylococcus aureus strains and
in intensive care unit patients, and it has increased among nosocomial
isolates of Klebsiella pneumoniae, Serratia marcescens, and Pseudomon
as aeruginosa. More worrisome are recent reports of an overall increas
e in resistance to fluoroquinolones among bacteria responsible,for com
munity-acquired infections, such as Escherichia coli, Salmonella speci
es, Campylobacter species and Neisseria gonorrhoeae.